CZ39894A3 - Pharmaceutical preparation for treating a state requiring vasodilator therapy - Google Patents

Pharmaceutical preparation for treating a state requiring vasodilator therapy Download PDF

Info

Publication number
CZ39894A3
CZ39894A3 CZ94398A CZ39894A CZ39894A3 CZ 39894 A3 CZ39894 A3 CZ 39894A3 CZ 94398 A CZ94398 A CZ 94398A CZ 39894 A CZ39894 A CZ 39894A CZ 39894 A3 CZ39894 A3 CZ 39894A3
Authority
CZ
Czechia
Prior art keywords
nitrite
dosage form
composition
patient
use according
Prior art date
Application number
CZ94398A
Other languages
Czech (cs)
English (en)
Inventor
Ho-Leung Fung
Anthony John Bauer
Original Assignee
Baker Norton Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baker Norton Pharma filed Critical Baker Norton Pharma
Publication of CZ39894A3 publication Critical patent/CZ39894A3/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CZ94398A 1992-07-02 1993-06-30 Pharmaceutical preparation for treating a state requiring vasodilator therapy CZ39894A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/908,224 US5278192A (en) 1992-07-02 1992-07-02 Method of vasodilator therapy for treating a patient with a condition

Publications (1)

Publication Number Publication Date
CZ39894A3 true CZ39894A3 (en) 1994-11-16

Family

ID=25425396

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ94398A CZ39894A3 (en) 1992-07-02 1993-06-30 Pharmaceutical preparation for treating a state requiring vasodilator therapy

Country Status (19)

Country Link
US (2) US5278192A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0604642A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JP2729333B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR0170789B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (1) CN1086997A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU667948B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2116785C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CZ (1) CZ39894A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HUT70501A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL106217A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX (1) MX9303982A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO305886B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ254490A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
OA (1) OA09890A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (1) PL302613A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SK (1) SK23594A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW (1) TW261530B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO1994001103A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA934771B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5278192A (en) * 1992-07-02 1994-01-11 The Research Foundation Of State University Of New York Method of vasodilator therapy for treating a patient with a condition
US5646181A (en) * 1992-07-02 1997-07-08 Research Foundation Of State University Of New York Method and compositions for treating impotence
GB9311920D0 (en) 1993-06-09 1993-07-28 Pfizer Ltd Therapeutic agents
US5973011A (en) * 1994-03-30 1999-10-26 Isis Pharma Gmbh Pharmaceutical preparations and medicaments for the prevention and treatment of endothelial dysfunction
US5681278A (en) * 1994-06-23 1997-10-28 Cormedics Corp. Coronary vasculature treatment method
US5594032A (en) * 1994-11-10 1997-01-14 Gonzalez-Cadavid; Nestor F. Amelioration of human erectile dysfunction by treatment with iNOS, inducers of iNOS or iNOS cDNA
US5665077A (en) * 1995-04-24 1997-09-09 Nitrosci Pharmaceuticals Llc Nitric oxide-releasing nitroso compositions and methods and intravascular devices for using them to prevent restenosis
US5645839A (en) * 1995-06-07 1997-07-08 Trustees Of Boston University Combined use of angiotensin inhibitors and nitric oxide stimulators to treat fibrosis
US5658936A (en) * 1995-09-18 1997-08-19 Brigham & Women's Hospital, Inc. Enhancement of erectile function with renin-angiotensin system inhibitors
US5897880A (en) 1995-09-29 1999-04-27 Lam Pharmaceuticals, Llc. Topical drug preparations
US6036977A (en) * 1995-09-29 2000-03-14 L.A.M. Pharmaceutical Corp. Drug preparations for treating sexual dysfunction
US6251436B1 (en) 1995-09-29 2001-06-26 L.A.M. Pharmaceutical Corporation Drug preparations for treating sexual dysfunction
US6387407B1 (en) 1995-09-29 2002-05-14 L.A.M. Pharmaceutical Corporation Topical drug preparations
WO1997027745A1 (en) * 1996-01-31 1997-08-07 Technology Licensing Co. L.L.C. Method of diagnosis and treatment and related compositions and apparatus
US6258032B1 (en) * 1997-01-29 2001-07-10 William M. Hammesfahr Method of diagnosis and treatment and related compositions and apparatus
GB9608408D0 (en) 1996-04-23 1996-06-26 Adams Michael A Treatment of erectile dysfunction
US5797887A (en) * 1996-08-27 1998-08-25 Novovasc Llc Medical device with a surface adapted for exposure to a blood stream which is coated with a polymer containing a nitrosyl-containing organo-metallic compound which releases nitric oxide from the coating to mediate platelet aggregation
US5958884A (en) * 1997-04-11 1999-09-28 The Brigham And Women's Hospital, Inc. Compositions and methods for treating erectile dysfunction
US6191156B1 (en) 1997-04-11 2001-02-20 The Brigham And Women's Hospital, Inc. Compositions and methods for treating bladder dysfunction
ZA989356B (en) * 1997-10-16 1998-11-16 Isis Pharma Gmbh Pharmaceutical preparations
US6056966A (en) * 1998-05-18 2000-05-02 Baker Norton Pharmaceuticals, Inc. Method and compositions for treating impotence
US6314956B1 (en) 1999-09-08 2001-11-13 Duke University Pulmonary delivery of NO group-containing compound in gas form to treat respiratory, cardiac and blood disorders
US7045152B2 (en) * 1999-09-08 2006-05-16 Duke University Treating pulmonary disorders with gaseous agent causing repletion of GSNO
WO2001098286A1 (en) 2000-06-22 2001-12-27 Nitromed, Inc. Nitrosated and nitrosylated taxanes, compositions and methods of use
IL153956A0 (en) * 2000-08-11 2003-07-31 Whitlock David R Compositions including ammonia oxidizing bacteria to increase production of nitric oxide and nitric oxide precursors and methods of using same
US20020172712A1 (en) * 2001-03-19 2002-11-21 Alan Drizen Antiemetic, anti-motion sustained release drug delivery system
WO2002083074A2 (en) * 2001-04-13 2002-10-24 Children's Hospital Medical Center Methods for the treatment of hepatic disorders
US20030026830A1 (en) * 2001-05-08 2003-02-06 Thomas Lauterback Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine
US20030027793A1 (en) * 2001-05-08 2003-02-06 Thomas Lauterback Transdermal treatment of parkinson's disease
US20030138494A1 (en) * 2001-05-15 2003-07-24 L.A.M. Pharmaceutical Corporation Drug preparations for treating sexual dysfunction
US20040225275A1 (en) * 2001-08-02 2004-11-11 Reynolds James Dixon Fetal physiology during maternal surgery or diagnosis
US6676855B2 (en) * 2001-08-02 2004-01-13 Duke University Use of a blood-flow decrease preventing agent in conjunction with insufflating gas
KR20040086267A (ko) * 2002-01-11 2004-10-08 데이비드 알. 휘트록 암모니아 산화 박테리아를 포함하는 조성물 및 그를사용하는 방법
US7691907B2 (en) 2002-03-06 2010-04-06 Duke University Methods and composition based on discovery of metabolism of nitroglycerin
US7776925B2 (en) * 2002-03-06 2010-08-17 Duke University Reversing, postponing or preventing the occurrence of GTN tolerance and/or generation of reactive oxygen species from mitochondria
US20060263419A1 (en) * 2002-03-12 2006-11-23 Hans-Michael Wolff Transdermal therapeutic system for Parkinson's Disease
US8822473B2 (en) * 2002-05-21 2014-09-02 Gilead Sciences, Inc. Method of treating diabetes
ES2523873T3 (es) 2002-05-21 2014-12-02 Gilead Sciences, Inc. Administración de un inhibidor parcial de la oxidación de ácidos grasos, tal como ranolazina, para el tratamiento de la diabetes
US6936639B2 (en) * 2002-08-21 2005-08-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Nitroxyl progenitors in the treatment of heart failure
WO2005063221A1 (en) * 2003-12-19 2005-07-14 Duke University Measuring vasodilating activity of blood samples to track disease course
WO2006110601A2 (en) * 2005-04-07 2006-10-19 Nitromed, Inc. The genetic risk assessment in heart failure: impact of the genetic variation of nos3
US20090209613A1 (en) * 2005-06-13 2009-08-20 Yeda Researc And Development Co. Ltd. At The Weizmann Institute Of Science Use of allymercaptocaptopril for treating or preventing obesity and obesity related diseases
CA2624933A1 (en) * 2005-10-04 2007-04-12 Nitromed, Inc. Methods for treating respiratory disorders
AU2007225489A1 (en) * 2006-03-14 2007-09-20 Lars E Gustafsson New method for the manufacture of therapeutic compounds and compositions, compounds and compositions produced therewhith, and their use
US7625852B2 (en) * 2006-06-07 2009-12-01 Henry Hadry Nail polish remover
US11229746B2 (en) 2006-06-22 2022-01-25 Excelsior Medical Corporation Antiseptic cap
US9259535B2 (en) 2006-06-22 2016-02-16 Excelsior Medical Corporation Antiseptic cap equipped syringe
EP2219657A4 (en) 2007-11-15 2020-01-08 Louisiana State University USE OF NITRITE SALTS IN CHRONIC ISCHEMIA
US9078992B2 (en) 2008-10-27 2015-07-14 Pursuit Vascular, Inc. Medical device for applying antimicrobial to proximal end of catheter
US20120237617A1 (en) 2009-06-18 2012-09-20 Theravasc Inc. Use of nitrite salts in treating tissue damage
WO2011047161A1 (en) * 2009-10-14 2011-04-21 TheraVasc, LLC Pharmaceutical formulations of nitrite and uses thereof
WO2011063339A1 (en) * 2009-11-23 2011-05-26 Cardioxyl Pharmaceuticals, Inc. Nitroxyl donors for the treatment of pulmonary hypertension
US20110144067A1 (en) * 2009-12-07 2011-06-16 Toscano John P N-Acyloxysulfonamide and N-Hydroxy-N-Acylsulfonamide Derivatives
AU2010328230B2 (en) * 2009-12-07 2016-06-02 Cardioxyl Pharmaceuticals, Inc. Bis-acylated hydroxylamine derivatives
US10166381B2 (en) 2011-05-23 2019-01-01 Excelsior Medical Corporation Antiseptic cap
EP2731658B1 (en) 2011-07-12 2020-04-01 Pursuit Vascular, Inc. Device for delivery of antimicrobial agent into trans-dermal catheter
EP2887927B1 (en) * 2012-08-23 2018-03-28 Cardiolynx AG Extended release compositions of an amino-c2-c6-alkyl nitrate
BR112015019802A2 (pt) 2013-02-20 2017-07-18 Theravasc Inc formulações farmacêuticas de nitrito e usos das mesmas
US11225640B2 (en) 2014-04-15 2022-01-18 Aobiome Llc Ammonia oxidizing bacteria for treatment of psoriasis
CN106456678A (zh) 2014-04-15 2017-02-22 Ao生物医学有限责任公司 氨氧化型亚硝化单胞菌菌株d23
EP3137122B1 (en) 2014-05-02 2019-09-04 Excelsior Medical Corporation Strip package for antiseptic cap
DK3294404T3 (da) 2015-05-08 2025-09-08 Icu Medical Inc Medicinske konnektorer konfigureret til at modtage emittere af terapeutiske midler
US10744316B2 (en) 2016-10-14 2020-08-18 Icu Medical, Inc. Sanitizing caps for medical connectors
WO2018204206A2 (en) 2017-05-01 2018-11-08 Icu Medical, Inc. Medical fluid connectors and methods for providing additives in medical fluid lines
US11517732B2 (en) 2018-11-07 2022-12-06 Icu Medical, Inc. Syringe with antimicrobial properties
US11541221B2 (en) 2018-11-07 2023-01-03 Icu Medical, Inc. Tubing set with antimicrobial properties
US11534595B2 (en) 2018-11-07 2022-12-27 Icu Medical, Inc. Device for delivering an antimicrobial composition into an infusion device
US11400195B2 (en) 2018-11-07 2022-08-02 Icu Medical, Inc. Peritoneal dialysis transfer set with antimicrobial properties
US11541220B2 (en) 2018-11-07 2023-01-03 Icu Medical, Inc. Needleless connector with antimicrobial properties
CA3118905A1 (en) 2018-11-21 2020-05-28 Icu Medical, Inc. Antimicrobial device comprising a cap with ring and insert
GB2579240B (en) * 2018-11-27 2020-12-16 Attgeno Ab New processes, compositions and medical uses
GB202007929D0 (en) * 2020-05-27 2020-07-08 Attgeno Ab New medical uses
US20240082198A1 (en) * 2020-10-01 2024-03-14 Emergent Product Development Gaithersburg Inc. Stabilized alkyl nitrite compositions
EP4255552A1 (en) 2020-12-07 2023-10-11 ICU Medical, Inc. Peritoneal dialysis caps, systems and methods

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3106511A (en) * 1961-12-14 1963-10-08 Revlon Amyl nitrite inhalant composition
CA1163195A (en) * 1980-06-26 1984-03-06 Alec D. Keith Polymeric diffusion matrix containing a vasodilator
US4450175A (en) * 1982-09-23 1984-05-22 Warshaw Thelma G Method and compositions for treating acne
DE3305690A1 (de) * 1983-02-18 1984-08-30 Heinrich Mack Nachf., 7918 Illertissen Glycerinmononitrate zur behandlung der angina pectoris
US4751087A (en) * 1985-04-19 1988-06-14 Riker Laboratories, Inc. Transdermal nitroglycerin delivery system
US4681584A (en) * 1985-05-03 1987-07-21 Alza Corporation Transdermal delivery system for delivering nitroglycerin at high transdermal fluxes
US4615699A (en) * 1985-05-03 1986-10-07 Alza Corporation Transdermal delivery system for delivering nitroglycerin at high transdermal fluxes
JPH06696B2 (ja) * 1987-01-27 1994-01-05 積水化学工業株式会社 テ−プ製剤
JPH06697B2 (ja) * 1987-01-27 1994-01-05 積水化学工業株式会社 テ−プ製剤
US4956181A (en) * 1987-05-08 1990-09-11 Eastman Kodak Nitrate therapy for angina pectoris
US5278192A (en) * 1992-07-02 1994-01-11 The Research Foundation Of State University Of New York Method of vasodilator therapy for treating a patient with a condition

Also Published As

Publication number Publication date
NO940691L (no) 1994-03-18
CN1086997A (zh) 1994-05-25
US5489610A (en) 1996-02-06
JPH06510800A (ja) 1994-12-01
OA09890A (en) 1994-09-15
TW261530B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1995-11-01
JP2729333B2 (ja) 1998-03-18
IL106217A0 (en) 1993-11-15
WO1994001103A1 (en) 1994-01-20
MX9303982A (es) 1994-02-28
CA2116785C (en) 1998-04-07
IL106217A (en) 1998-04-05
KR0170789B1 (ko) 1999-02-01
HU9400627D0 (en) 1994-06-28
NO305886B1 (no) 1999-08-16
PL302613A1 (en) 1994-09-05
SK23594A3 (en) 1994-08-10
NZ254490A (en) 1997-08-22
ZA934771B (en) 1994-01-20
NO940691D0 (no) 1994-02-28
AU667948B2 (en) 1996-04-18
AU4658793A (en) 1994-01-31
US5278192A (en) 1994-01-11
HUT70501A (en) 1995-10-30
CA2116785A1 (en) 1994-01-20
EP0604642A1 (en) 1994-07-06

Similar Documents

Publication Publication Date Title
CZ39894A3 (en) Pharmaceutical preparation for treating a state requiring vasodilator therapy
Calne et al. Idiopathic Parkinsonism treated with an extracerebral decarboxylase inhibitor in combination with levodopa
JPH09505807A (ja) プリン組成物および投与方法
ES2202326T3 (es) Uso de cetoconazol y sustancias relacionadas en medicamentos para el tratamiento de la diabetes de tipo ii.
US4416893A (en) Substituted 1,2,5-oxadiazole-2-oxides in human cardiovascular system disease
WO2007048353B1 (en) Pharmaceutical composition and method for neoangiogenesis/revascularization useful in treating ischemic heart diseases
JPH1095731A (ja) 水酸基ラジカル消去剤
CN103833712B (zh) 硝克柳胺化合物晶ii型、其制法和其药物组合物与用途
JPH08509749A (ja) 活性物質投与用の経皮治療システム
JPS5888312A (ja) カルニチンまたは低級アシルカルニチンからなる静脈疾患治療剤
ES2234933T3 (es) Utilizacion de opiaceos debiles y mixtos agonistas/antagonistas para el tratamiento de la incontinencia urinaria.
BR112019010809A2 (pt) composto de fórmula i, composto de fórmula ii, composto de fórmula iii, composto de fórmula iv, composto de fórmula v, composto de fórmula vi, composto de fórmula vii, composto de fórmula viii, composto de fórmula ix, composto de fórmula x, composto de fórmula xi, composto de fórmula xii, e composição farmacêutica
Rea et al. Hypotensive action of chlorpromazine
ITMI950532A1 (it) Derivato di aminotetralina per la terapia di malattie cardiovascolari
US11648240B2 (en) Pharmaceutical composition comprising famotidine, lidocaine and melatonin
Van Wezel et al. Comparison of nitroglycerine, verapamil and nifedipine in the management of arterial pressure during coronary artery surgery
TW202027744A (zh) 胺基甲酸酯化合物於預防、緩解或治療糖尿病周邊神經病變或化療誘發的周邊神經病變的用途
KR20020002487A (ko) 협심증 치료를 위한 바소펩티다제 억제제의 용도
JP2000219626A (ja) ケロイドおよび／または肥厚性瘢痕の治療剤
Chan et al. Antihypertensive activity and effects on blood flow of CL 115,999 (5‐lodo‐5, 6‐dihydro‐15‐deoxy‐16‐hydroxy‐16‐vinyl‐prostacyclin methyl ester), a new potent orally and transdermally long‐acting prostacyclin analog
WO2022157563A1 (en) A pharmaceutical composition comprising lidocaine and melatonin
Distante et al. May prolonged high doses of nitrates cause tolerance? Preliminary results on the response to an additional dose by infusion
US6897239B1 (en) Use of misoprostol and/or metabolites of misoprostol for treating sexual dysfunction in women
Bassenge et al. Long term increases in coronary arterial conductance during five day infusion of low dose nicorandil
US20220233504A1 (en) Pharmaceutical composition comprising lidocaine and melatonin

Legal Events

Date Code Title Description
PD00 Pending as of 2000-06-30 in czech republic